In April 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4132 (the Athlete) after her sample tested positive for the prohibited substance clomiphene. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Japan Anti-Doping Disciplinary Panel.
The Athlete stated, sustained by evidence, that she had used prescribed medication as treatment for her condition a month before she provided a sample.
With non intentional use the Panel finds that the Athlete failed to mention to her doctor that she was an athlete and subject to doping tests. Also she did not research the ingredients of her prescribed medication before using.
Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 15 April 2012 to impose a 3 month period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 6 April 2012.
